Skip to main content

Table 1 Comparison of the baseline demographics of elderly and younger pancreatic cancer patients (n = 895)

From: Efficacy of chemotherapy in elderly patients with unresectable pancreatic cancer: a multicenter review of 895 patients

  Total (n = 895) Elderly group (n = 659) Younger group (n = 236) P-value
Age (y) 71.9 ± 11.1 77.2 ± 6.9 57.2 ± 6.1 NA
Sex (Female) 435 (48.6%) 354 (53.7%) 81 (34.3%) <.0001
Tumor location, including the pancreatic head 506 (56.5%) 376 (57.1%) 130 (55.1%) 0.51
Stage I 15 (1.7%) 13 (2.0%) 2 (0.8%) 0.25
II 18 (2.0%) 16 (2.4%) 2 (0.8%) 0.14
III 57 (6.4%) 39 (5.9%) 18 (7.7%) 0.36
IVa 232 (25.9%) 172 (26.1%) 60 (25.4%) 0.84
IVb 573 (64.0%) 419 (63.6%) 154 (65.3%) 0.65
Treatment CT 519 (58.0%) 344 (43.4%) 175 (60.3%) <.0001
BSC 376 (42.0%) 315 (39.8%) 61 (21.0%) <.0001
Death resulting from PC 584 (96.1%) 419 (95.2%) 165 (98.2%) 0.09
  1. Elderly group: patients aged ≥65 years; Younger group: patients aged <65 years
  2. Abbreviations: CT chemotherapy, BSC best supportive care, PC pancreatic cancer, NA not applicable